These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20061717)

  • 1. SLE Conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):163. PubMed ID: 20061717
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y; Lu Q
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taming lupus.
    Zouali M
    Sci Am; 2005 Mar; 292(3):58-65. PubMed ID: 15859214
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.
    Lei W; Luo Y; Lei W; Luo Y; Yan K; Zhao S; Li Y; Qiu X; Zhou Y; Long H; Zhao M; Liang Y; Su Y; Lu Q
    Scand J Rheumatol; 2009; 38(5):369-74. PubMed ID: 19444718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus.
    Rahman A; Isenberg DA
    N Engl J Med; 2008 Feb; 358(9):929-39. PubMed ID: 18305268
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.
    Huggins JL; Brunner HI
    J Pediatr; 2006 May; 148(5):571-3. PubMed ID: 16737861
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus.
    Deng YJ; Huang ZX; Zhou CJ; Wang JW; You Y; Song ZQ; Xiang MM; Zhong BY; Hao F
    Mol Immunol; 2006 Mar; 43(9):1497-507. PubMed ID: 16143398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus.
    Vieira QF; Kayser C; Kallas EG; Andrade LE
    J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
    Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
    Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
    Sousa E; Isenberg D
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus.
    Zhang Y; Zhao M; Sawalha AH; Richardson B; Lu Q
    J Autoimmun; 2013 Mar; 41():92-9. PubMed ID: 23340289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab to treat active SLE in a hemodialysis patient.
    Nadri QJ
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1085-6. PubMed ID: 19861879
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports.
    Lim SW; Gillis D; Smith W; Hissaria P; Greville H; Peh CA
    Intern Med J; 2006 Apr; 36(4):260-2. PubMed ID: 16640745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus in children: current and emerging therapies.
    Macdermott EJ; Adams A; Lehman TJ
    Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.